Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Sep-21 10:00 PM View:  | Rvl Pharmaceuticals Plc (RVLP) | 27-Aug-21 | Payment of Exercise | 5,506 | $3.31 | $18,224.90 | (4%) 123.97K to 118.47K | (5%) |
| 07-Jul-21 4:05 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 02-Jul-21 | Grant | 61,188 | -- | -- | 97% 62.78K to 123.97K | |
| 22-Jun-21 4:06 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-Jun-21 | Payment of Exercise | 18,584 | $2.89 | $53,707.80 | (23%) 81.37K to 62.78K | < 1% |
| 26-Jan-21 7:01 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-21 | Payment of Exercise | 5,505 | $4.46 | $24,552.30 | (6%) 86.87K to 81.37K | (3%) |
| 22-May-20 4:27 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 21-May-20 | Payment of Exercise | 17,778 | $4.60 | $81,778.80 | (17%) 104.65K to 86.87K | |
| 22-May-20 4:27 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 20-May-20 | Grant | 38,716 | -- | -- | 59% 65.94K to 104.65K | |
| 30-Jan-20 5:38 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 28-Jan-20 | Payment of Exercise | 5,505 | $7.00 | $38,535.00 | (8%) 71.44K to 65.94K | |
| 19-Jun-19 4:59 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-Jun-19 | Grant | 37,037 | -- | -- | 108% 34.4K to 71.44K | |
| 28-Jan-19 5:50 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-19 | Grant | 34,403 | -- | -- | 100% 0 to 34.4K | |
| 04-May-18 6:19 PM View: | Allergan Plc (AGN) | 02-May-18 | Grant | 1,985 | $151.07 | $299,874.00 | 7% 27.69K to 29.68K | (2%) |
| 05-May-17 6:29 PM View: | Allergan Plc (AGN) | 04-May-17 | Grant | 1,223 | $245.25 | $299,941.00 | 5% 26.47K to 27.69K | (40%) |
| 05-May-17 6:29 PM View: | Allergan Plc (AGN) | 03-May-17 | Payment of Exercise | 668 | $243.76 | $162,832.00 | (2%) 27.14K to 26.47K | 40% |
| 09-Aug-16 3:02 PM View: | Allergan Plc (AGN) | 08-Aug-16 | Grant | 201 | $248.31 | $49,910.30 | < 1% 26.93K to 27.14K | (41%) |
| 09-May-16 5:07 PM View: | Allergan Plc (AGN) | 05-May-16 | Grant | 1,188 | $210.34 | $249,884.00 | 5% 25.75K to 26.93K | (31%) |
| 08-Jun-15 5:25 PM View: | Allergan Plc (AGN) | 05-Jun-15 | Grant | 826 | $302.30 | $249,700.00 | 3% 24.87K to 25.69K | (52%) |
| 08-Jun-15 5:25 PM View: | Allergan Plc (AGN) | 04-Jun-15 | Payment of Exercise | 549 | $303.38 | $166,556.00 | (2%) 25.42K to 24.87K | 52% |
| 13-May-14 5:20 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 1,142 | $197.05 | $225,031.00 | 5% 24.27K to 25.42K | (26%) |
| 18-Nov-13 4:30 PM View: | Allergan Plc (AGN) | 14-Nov-13 | Market Sale | 3,000 | $164.15 | $492,450.00 | (11%) 27.27K to 24.27K | 11% |
| 02-Oct-13 9:26 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 27,275 | -- | -- | (100%) 27.27K to 0 | |
| 03-Oct-13 4:42 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 27,275 | -- | -- | 100% 0 to 27.27K | |
| 14-May-13 1:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 10-May-13 | Grant | 1,877 | -- | -- | 7% 25.4K to 27.27K | |
| 31-Jul-12 12:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Jul-12 | Option Exercise | 30,000 | $36.57 | $1,097,100.00 | 118% 25.4K to 55.4K | |
| 31-Jul-12 12:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Jul-12 | Market Option Sale | 30,000 | $78.78 | $2,363,400.00 | (54%) 55.4K to 25.4K | 71% |
| 14-May-12 6:04 PM View: | Watson Pharmaceuticals Inc. (ACT) | 11-May-12 | Grant | 2,887 | -- | -- | 13% 22.51K to 25.4K | |
| 17-May-11 4:47 PM View: | Watson Pharmaceuticals Inc. (ACT) | 13-May-11 | Grant | 3,177 | -- | -- | 16% 19.33K to 22.51K | |
| 17-Dec-10 4:12 PM View: | Watson Pharmaceuticals Inc. (ACT) | 15-Dec-10 | Option Exercise | 30,000 | $48.48 | $1,454,400.00 | 155% 19.33K to 49.33K | (53%) |
| 17-Dec-10 4:12 PM View: | Watson Pharmaceuticals Inc. (ACT) | 15-Dec-10 | Market Option Sale | 30,000 | $51.02 | $1,530,460.00 | (61%) 49.33K to 19.33K | 56% |
| 11-May-10 4:26 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-May-10 | Grant | 5,000 | -- | -- | 35% 14.33K to 19.33K | |
| 11-May-09 4:45 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-May-09 | Grant | 5,000 | -- | -- | 54% 9.33K to 14.33K | |
| 12-May-08 5:06 PM View: | Watson Pharmaceuticals Inc. (ACT) | 09-May-08 | Grant | 5,000 | -- | -- | 115% 4.33K to 9.33K | |
| 07-May-07 7:36 PM View: | Watson Pharmaceuticals Inc. (ACT) | 04-May-07 | Grant | 3,334 | -- | -- | 333% 1.0K to 4.33K |